An atypical antipsychotic that is used (in the form of its tartrate salt) for treatment of hallucinations and delusions associated with Parkinson's disease.
Pimavanserin tartrate is a medication sold under the brand name Nuplazid. It is an atypical antipsychotic medication that is specifically approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis .
Here's a summary of Pimavanserin Tartrate:
- Type of drug: Atypical antipsychotic
- Brand name: Nuplazid
- Uses: Treats hallucinations and delusions associated with Parkinson's disease psychosis
- How it works: Exact mechanism unknown, but it interacts with serotonin receptors, particularly the 5-HT2A and HT2C receptors. Unlike other atypical antipsychotics, it does not block dopamine receptors, which can cause movement problems.
Important to note:
- Pimavanserin tartrate is only available by prescription.
- It is not a cure for Parkinson's disease psychosis, but it can help to improve symptoms.
- There can be side effects associated with taking pimavanserin tartrate, so it is important to talk to your doctor about the risks and benefits before starting treatment.
Anatomical Therapeutic Chemical Classification
N - Nervous system
N05 Psycholeptics
N05A - Antipsychotics
N05AX Other antipsychotics
ATC Code
External Links
Pimavaserin Tartrate